Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures

Clinical trial NCT07092605 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07092605
Sponsor: AgelessRx
Status: ENROLLING_BY_INVITATION
Phase: Early Phase 1
Study type: INTERVENTIONAL

Longevity Quality of Life Mood Inflammation Immune Health Pain Management Weight Management Alertness

Start date: 2024-11-01
Primary completion: 2025-11-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.